RICHMOND, Va.–(BUSINESS WIRE)–Holon Health, a primary care and psychiatry provider that bridges gaps in care for people with substance use disorder (SUD) and/or mental health conditions, announced that West Huddleston — one of the nation’s top leaders in justice reform and behavioral health — has joined its leadership team as the Chief Growth Officer. With … [Read more…]
Multi-award-winning R&B artist will perform at the 34th annual AIDS Walk & Music Festival on September 27, 2025 in Piedmont Park ATLANTA–(BUSINESS WIRE)–Five-time Grammy Award-winning singer, songwriter, producer, and one of the most celebrated pop culture and fashion icons, CeeLo Green, is using his star power to shine a spotlight on the ongoing fight against … [Read more…]
CAMBRIDGE, England–(BUSINESS WIRE)–Healx, a pioneer in AI-powered drug discovery for rare and neglected conditions, has partnered with SCI Ventures – the world’s first specialist venture fund focused on curing paralysis- to accelerate the discovery and development of therapies for spinal cord injury (SCI) using artificial intelligence. This first-of-its kind collaboration will apply Healx’s cutting-edge AI … [Read more…]
SENS-501, including the surgical delivery of the gene therapy, shows a good safety profile in all patients treated so far Three-month results from a SENS-501 treated toddler in the first cohort demonstrate early promising hearing improvement The second cohort assessing a higher dose of SENS-501 is ongoing and recruitment is close to being completed MONTPELLIER, … [Read more…]
— Enabling Scalable, Non-Viral Cell Engineering for Research, Biomanufacturing, and Therapeutic Development — TOKYO–(BUSINESS WIRE)–The Biomedical Division of PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as “PHCbi”), a subsidiary of PHC Holdings Corporation (Headquarters: Chiyoda-ku, Tokyo, hereafter referred to as “PHCHD”) announces it has signed an exclusive agreement with MaxCyte, Inc. … [Read more…]
– Funding agreement contemplates a conversion formula with a potential 30% premium upon conversion and positions the Company for growth, and accelerated advancement of its clinical pipeline programs, CYB003 and CYB004 – TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American: CYBN) (Cboe Canada: CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare … [Read more…]
Written agreement from FDA for single-arm, open-label, baseline-controlled registrational trial evaluating composite primary endpoint of improvement in CGI-I and gain of developmental milestone/skill by video capture Written agreement from FDA to evaluate NGN-401 in females with Rett syndrome ages 3 years and older based on natural history study analysis Registrational trial initiation activities underway Phase … [Read more…]
TORRANCE, Calif.–(BUSINESS WIRE)–Reproductive Partners Medical Group (RPMG), a nationally recognized leader in fertility care and a member of the Ivy Fertility network, invites the community to celebrate the opening of its new South Bay clinic at an Open House event on Friday, July 11th, from 5:30 to 8:00 PM. Located in the heart of South … [Read more…]
Bosch, BT International, Johnson & Johnson, McCormick & Company, Inc., Roche Turkiye, and Schneider Electric Recognized for Their Innovative Use of AI MIAMI–(BUSINESS WIRE)–$HCKT #AICenterOfExcellence—The Hackett Group, Inc. (NASDAQ: HCKT), a leading generative artificial intelligence (Gen AI) consultancy and executive advisory firm, today announced the winners of its inaugural Hackett Innovation Awards, which recognize companies … [Read more…]
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter financial results on Wednesday, July 30, 2025. The company will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a … [Read more…]
